CJS Securities began coverage on shares of Transcat (NASDAQ:TRNS – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. The firm issued an outperform rating and a $115.00 price target on the scientific and technical instruments company’s stock.
TRNS has been the subject of a number of other reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Northland Securities upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price on the stock in a research note on Wednesday, October 21st. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $105.00.
Read Our Latest Analysis on TRNS
Transcat Trading Up 1.3%
TRNS opened at $90.00 on Tuesday. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $100.00. The firm has a market capitalization of $845.10 million, a PE ratio of 243.24 and a beta of 0.66. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.49 and a quick ratio of 2.11. The company’s 50-day moving average is $86.25 and its 200 day moving average is $81.48.
Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%. The business had revenue of $92.95 million for the quarter, compared to analysts’ expectations of $86.55 million. As a group, research analysts predict that Transcat will post 1.79 earnings per share for the current fiscal year.
Insider Buying and Selling at Transcat
In other news, Director Craig Cairns acquired 1,050 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was purchased at an average cost of $93.97 per share, for a total transaction of $98,668.50. Following the acquisition, the director owned 1,480 shares of the company’s stock, valued at $139,075.60. This trade represents a 244.19% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Christopher P. Gillette sold 504 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $94.23, for a total value of $47,491.92. Following the completion of the transaction, the director owned 200 shares of the company’s stock, valued at $18,846. The trade was a 71.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by insiders.
Institutional Trading of Transcat
A number of institutional investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC bought a new stake in shares of Transcat during the 2nd quarter valued at about $32,000. Persistent Asset Partners Ltd purchased a new position in shares of Transcat during the second quarter valued at about $52,000. GAMMA Investing LLC raised its stake in Transcat by 133.6% in the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock worth $91,000 after buying an additional 589 shares in the last quarter. Canada Pension Plan Investment Board bought a new position in Transcat in the second quarter worth about $204,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Transcat in the second quarter worth about $226,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.
Transcat Company Profile
Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.
Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.
Featured Articles
- Five stocks we like better than Transcat
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
